首页 | 本学科首页   官方微博 | 高级检索  
     


Wnt signaling and hepatocarcinogenesis: Molecular targets for the development of innovative anticancer drugs
Authors:Floriane Pez,Anaï  s Lopez,Miran Kim,Jack R. Wands,Claude Caron de Fromentel,Philippe Merle
Affiliation:1 INSERM U1052, CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, F-69008 Lyon, France;2 Université Lyon-1, F-69622 Villeurbanne, France;3 Centre Léon Bérard, F-69008 Lyon, France;4 The Liver Research Center, Brown University, Providence, RI, USA;5 Hospices Civils de Lyon, Service d’Hépatologie et de Gastroentérologie, Groupement Hospitalier Lyon Nord, F-69000 Lyon, France
Abstract:
Keywords:HCC, hepatocellular carcinoma   FZD, frizzled   CSC, cancer stem cells   PCP, planar cell polarity   TCF/LEF, T-cell factor/lymphoid enhancer factor   TLE-1, transducin like enhancer-1   APC, adenomatous polyposis coli protein   GSK3β, glycogen synthase kinase 3β   CK1, casein kinase 1   β-TRCP, beta-transducin repeat containing protein   SCF, Skp1/cullin F-box complex   Dvl/Dsh, disheveled   Pygo, pygopus   CBP, CREB-binding protein   PKC, protein kinase C   NFAT, nuclear factor of activated T cell   NLK, Nemo-like kinase   Wif1, Wnt inhibitory protein-1   sFRP, secreted FZD-related proteins   Dkk, Dickkopf   Krm, Kremen   Rspo, R-spondin   Gpc3, glypican-3   DIFs, differentiation-inducing factors
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号